Literature DB >> 12756831

[The personal data act, clinical trials and data privacy. Rules for treatment of personal data in clinical trials and scientific research projects].

Camilla Daasnes1.   

Abstract

The Danish Act on Processing of Personal Data applies to all processing of data for the purpose of carrying out medical trials and other scientific or statistical studies. Prior to the commencement of the processing of data, a private controller, i.e. a pharmaceutical company, shall notify the Danish Data Protection Agency and obtain the authorisation of the Agency. The article presents the various conditions laid down by the Agency for the carrying out of the processing operations. Furthermore, special attention is drawn to the data subject's various rights. In order to ensure the privacy of the data subject and to protect data against accidental or unlawful destruction, loss or alteration and against unauthorized disclosure, the controller shall implement certain technical and organisational security measures laid down by the Agency. When a controller leaves the processing of data to a processor, the processor is obliged to ensure compliance with the given measures. The Data Protection Agency supervises that the processing is carried out in compliance with the provisions of the Act and the conditions laid down by the Agency.

Mesh:

Year:  2003        PMID: 12756831

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  2 in total

1.  Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.

Authors:  Casper H Jørgensen; Gunnar H Gislason; Charlotte Andersson; Ole Ahlehoff; Mette Charlot; Tina K Schramm; Allan Vaag; Steen Z Abildstrøm; Christian Torp-Pedersen; Peter R Hansen
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

2.  Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus.

Authors:  Casper H Jørgensen; Gunnar H Gislason; Ole Ahlehoff; Charlotte Andersson; Christian Torp-Pedersen; Peter R Hansen
Journal:  BMC Cardiovasc Disord       Date:  2014-01-09       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.